Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL
CHI home
about
contact us
request information
Home
All Reports
How To Order
Affiliated Reports
About Us
Contact Us
Therapies for Solid Tumors
September 2012
Table of Contents
|
Tables and Figures
Single User - $1,495.00
Single Site - $2,995.00
Multi Site - $7,950.00
Alzheimer's Disease
July 2012
Table of Contents
|
Tables and Figures
Single User - $595.00
High-Content Analysis Report
December 2011
Table of Contents
|
Tables and Figures
Single User - $795.00
Single Site - $3,995.00
Multi Site - $9,950.00
The PI3K/Akt/mTOR Pathway
November 2011
Table of Contents
|
Tables and Figures
|
Executive Summary
Single User - $2,495.00
Single Site - $3,995.00
Multi Site - $9,950.00
Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
September 2011
Table of Contents
|
Tables and Figures
|
Executive Summary
Single User - $2,495.00
Single Site - $3,995.00
Multi Site - $9,995.00
Kinase-Targeted Therapeutics
August 2011
Table of Contents
|
Tables and Figures
|
Executive Summary
Single User - $595.00
Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid Arthritis
July 2011
Table of Contents
|
Tables and Figures
Single User - $795.00
Multitargeted Therapies
June 2011
Table of Contents
|
Tables and Figures
Single User - $3,195.00
Single Site - $3,995.00
Multi Site - $9,950.00
Nuclear Receptors: The Pipeline Outlook
September 2010
Table of Contents
|
Tables and Figures
|
Executive Summary
Single User - $3,195.00
Single Site - $3,995.00
Multi Site - $9,950.00
Epigenetic Drug & Diagnostic Pipelines
June 2010
Table of Contents
|
Tables and Figures
|
Executive Summary
Single User - $3,195.00
Single Site - $3,995.00
Multi Site - $9,950.00
First
1
2
3
Last
Autoimmune Disorders-Pipeline Review, H1 2013
February 2013
Single User - $2,000.00
Single Site - $4,000.00
Multi Site - $6,000.00
Toll-Like Receptor (TLR) Agonists & Antagonists
December 2012
Single User - $910.00
Single Site - $1,820.00
Multi Site - $2,730.00
Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and Biosuperiors
November 2012
Single User - $392.58
Single Site - $785.16
Multi Site - $1,177.74
Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors
November 2012
Single User - $392.58
Single Site - $785.16
Multi Site - $1,177.74
Inflammatory Partnering 2007-2012
September 2012
Single User - $995.00
Single Site - $2,995.00
Multi Site - $4,975.00
Immunology Partnering Terms and Agreements
September 2012
Single User - $2,695.00
Single Site - $8,095.00
Multi Site - $13,475.00
Mucositis Partnering 2007-2012
September 2012
Single User - $995.00
Single Site - $2,995.00
Multi Site - $4,975.00
Allergic Rhinitis Partnering 2007-2012
August 2012
Single User - $995.00
Single Site - $1,495.00
Multi Site - $4,975.00
Asthma Partnering 2007-2012
August 2012
Single User - $995.00
Single Site - $1,495.00
Multi Site - $4,975.00
COPD Partnering 2007-2012
August 2012
Single User - $995.00
Single Site - $1,495.00
Multi Site - $4,975.00
First
1
2
3
Last
ALL REPORTS
ALL REPORTS
2013
2012
2011
2010
2009
2008
2007
2006
2005
SERIES
Biological Therapeutic Products
Biomarkers & Diagnostics
BioPharma Strategy
Emerging and International Markets and Outsourcing:
Market Outlook, Strategies, Licensing and Mergers and Acquisitions
MSL-KOL
Outsourcing
Pharmaceutical Marketing
Resource Guides
Bioprocess & Manufacturing
Chemistry
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
Biosimilars & Generic Markets
Imaging
Drug Targets
Genomics
Healthcare
IT & Informatics
Technology & Tools for Life Science
Therapeutic Indications
Adrenal Diseases
Alzheimer’s Disease
Anti-Viral and Therapeutics
Autoimmune Diseases and Therapeutics
Blood Disorders and Diseases
Cancer Research and Therapeutics
Cardiovascular
CNS
Diabetes
Epidemiology
Liver Diseases
Neurological Diseases and Therapeutics
Pain Management
Respiratory Disease and Therapeutics
Vaccines
Women’s Health